Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
about
Immune Checkpoint Modulators: An Emerging Antiglioma ArmamentariumAntibody-based immunotherapy for malignant glioma.Generation of CAR T cells for adoptive therapy in the context of glioblastoma standard of care.A standardized and reproducible protocol for serum-free monolayer culturing of primary paediatric brain tumours to be utilized for therapeutic assays.Anti-miR delivery strategies to bypass the blood-brain barrier in glioblastoma therapyTargeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice.The Role of Immune Checkpoint Inhibition in the Treatment of Brain Tumors.Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide.Temozolomide increases MHC-I expression via NF-κB signaling in glioma stem cells.Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide.
P2860
Q26765459-81AD2E07-E3F1-4381-A8B7-74735EBD7234Q34120472-AD1678D8-2F0F-4A73-9853-9182EE6ECDD4Q35162266-8FC4874F-50C9-462A-AF5F-DF347DDBD9FCQ35860191-1CDA41AF-6289-45CE-B7A2-A8C1A25308ECQ37301832-43057A65-7746-4E29-B6E8-101309411B36Q37731326-F06DEF7D-BFF4-403B-B07F-69A129F81079Q38930244-5874AB9D-F989-40D7-9782-0D6227D9142FQ48344360-86CE51ED-AC6C-4B8C-A5EC-3EE397DE7D4EQ50732365-B0340A22-481F-440F-85BE-E8D3AA6BAC6AQ52597547-2E2E7428-074A-4251-B928-26BA04E1677C
P2860
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
@ast
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
@en
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
@nl
type
label
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
@ast
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
@en
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
@nl
prefLabel
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
@ast
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
@en
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
@nl
P2093
P2860
P1476
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion
@en
P2093
Anna Darabi
Edward Visse
Emma Sandén
Sara Fritzell
Sofia Eberstål
P2860
P2888
P304
P356
10.1007/S00262-013-1449-Z
P50
P577
2013-06-18T00:00:00Z
P6179
1021272403